drugset / Trial / NCT05475873

Ondansetron for Postspinal Anesthesia Hypotension

NCT05475873

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effectiveness of ondansetron for postspinal anesthesia hypotension in patients undergoing cesarean section.

Timeline

Start
2023-06-18
Primary completion
2023-10-27
Completion
2023-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg Intravenous
Subject Ondansetron Other / unclassified 8 mg Intravenous

Indications

No indication recorded.